IA
XERS icon

IFP Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

IFP Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35 Sell
6
-134
-96% -$888 ﹤0.01% 4876
2025
Q4 		$1.1K Buy
140
+120
+600% +$944 ﹤0.01% 4045
2025
Q3 		$163 Sell
20
-60
-75% -$399 ﹤0.01% 4436
2025
Q2 		$374 Buy
80
+54
+208% +$247 ﹤0.01% 4504
2025
Q1 		$143 Hold
26
– – ﹤0.01% 3765
2024
Q4 		$88 Sell
26
-174
-87% -$560 ﹤0.01% 4080
2024
Q3 		$570 Hold
200
– – ﹤0.01% 3137
2024
Q2 		$450 Hold
200
– – ﹤0.01% 3098
2024
Q1 		$442 Hold
200
– – ﹤0.01% 2990
2023
Q4 		$470 Hold
200
– – ﹤0.01% 2881
2023
Q3 		$372 Hold
200
– – ﹤0.01% 3133
2023
Q2 		$524 Hold
200
– – ﹤0.01% 3190
2023
Q1 		$472 Hold
200
– – ﹤0.01% 3191
2022
Q4 		$1K Hold
200
– – ﹤0.01% 4519
2022
Q3 		$1K Hold
200
– – ﹤0.01% 4708
2022
Q2 		$1K Hold
200
– – ﹤0.01% 4477
2022
Q1 		$1K Hold
200
– – ﹤0.01% 4475
2021
Q4 		$1K Hold
200
– – ﹤0.01% 3149
2021
Q3 		$1K Hold
200
– – ﹤0.01% 3160
2021
Q2 		$1K Hold
200
– – ﹤0.01% 2966
2021
Q1 		$1K Buy
+200
New +$1.08K ﹤0.01% 2898
2018
Q4 		– Sell
-200
Closed -$4K – 3897
2018
Q3 		$4K Buy
+200
New +$4.34K ﹤0.01% 3337

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IFP Advisors's XERS Position: Q1 2026 in Review

IFP Advisors reduced its Xeris Biopharma Holdings (XERS) stake by 96% in Q1 2026, selling an estimated $888 and leaving 6 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #4876.

IFP Advisors first reported a position in XERS in Q3 2018 and has held it in 22 quarters since. The position peaked at $4K in Q3 2018. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • IFP Advisors held 6 shares of Xeris Biopharma Holdings worth $35 as of Q1 2026.
  • IFP Advisors sold 134 Xeris Biopharma Holdings shares in Q1 2026, an estimated $888.
  • Xeris Biopharma Holdings made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4876 holding.
  • IFP Advisors first reported a position in Xeris Biopharma Holdings in Q3 2018 and has held it in 22 quarters since.
  • IFP Advisors's Xeris Biopharma Holdings position peaked at $4K in Q3 2018.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.